|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Aug. 14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Aug. 13 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 3.15M 2.71M 2.55M 2.33M 4.35M 297M 4.36M 30.09M 11.68M 152M 11.81M 11.55M 491M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25M 21.51M 20.24M 18.49M 34.59M 2.36B 34.68M 239M 92.81M 1.21B 93.87M 91.83M 3.9B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 2023-03-20 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 2023-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | -2.83% | +53.63% | +104.47% | 1,034B | |
| -1.06% | +2.80% | +54.14% | +71.48% | 671B | |
| -1.50% | +0.30% | +20.31% | +75.39% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.59% | +1.01% | +55.94% | +71.96% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.46% | +3.21% | +33.32% | +100.04% | 188B | |
| Average | -1.00% | +1.27% | +28.10% | +51.71% | 412.97B | |
| Weighted average by Cap. | -1.10% | +1.04% | +36.29% | +66.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.56M 23.1M 21.11M 39.48M 2.69B 39.59M 273M 106M 1.38B 107M 105M 4.45B | 20.71M 17.82M 16.77M 15.32M 28.66M 1.96B 28.73M 198M 76.89M 1B 77.78M 76.08M 3.23B |
| Net income | -39.26M -33.78M -31.78M -29.03M -54.31M -3.71B -54.46M -376M -146M -1.9B -147M -144M -6.13B | -48.06M -41.35M -38.91M -35.54M -66.49M -4.54B -66.67M -460M -178M -2.33B -180M -177M -7.5B |
| Net Debt | 6.05M 5.21M 4.9M 4.47M 8.37M 571M 8.39M 57.88M 22.46M 293M 22.72M 22.22M 944M | 21.85M 18.81M 17.69M 16.16M 30.24M 2.06B 30.32M 209M 81.13M 1.06B 82.06M 80.27M 3.41B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
